AI's impact on medicine is profound, with unique advances in medical research, physician training, and patient care. Lloyd Minor's examination of ChatGPT revealed its potential in understanding rare medical conditions. Notable advancements in research, such as AlphaFold2 from Google DeepMind, enable accurate predictions of protein structures, facilitating drug design. This model has gained global utilization, leading to the creation of AI-designed treatments, including the recent Phase II clinical trial of a drug for idiopathic pulmonary fibrosis, signaling significant progress in AI-driven therapies.
The way it assimilated the information and presented it was really quite remarkable. And that's when I realized this is not just an incremental advance.
Machine learning model AlphaFold2 made it possible to predict the structure of virtually all the 200 million proteins that researchers have identified.
AlphaFold2 has since been used by more than 2 million people from 190 countries, earned its creators the Nobel Prize, and ignited a boom of new biotech startups.
Last year, the first AI-targeted and AI-designed drug reached Phase II clinical trials, marking a new milestone for the technology.
Collection
[
|
...
]